US aid program sending Norplant contraceptive to Third World despite health concerns
October 12, 2012
The US Agency of International Development (AID) has announced plans to provide the the long-term Norplant contraceptive to women in developing countries.
Norplant is not distributed in advanced countries, primarily because of complaints that users developed health problems. Nearly two-thirds of women using the implanted contraceptive reported bleeding, and Norplant marketing was discontinued in the US after a series of lawsuits against the manufacturer.
AID is distributing Jadelle, a second-generation form of Norplant. Jadelle was approved for use in the US in 1996, but has not been introduced to the American market because of concerns about side effects.